在健康和癌症中使用CMGC Kinases
Iftekhar Chowdhury1,2, Giovanna Dashi1,2, Salla Keskitalo1,2
1Institute of Biotechnology, University of Helsinki, 00014 Helsinki, Finland.
在细胞信号传递和癌症中,CMGC激酶至关重要. 用抑制剂向这些激酶是有希望的,但克服耐药性和提高选择性是未来癌症治疗的关键.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- CMGC激酶 (CDK,MAPK,GSK,CLK) 调节细胞周期和基因表达等重要细胞过程.
- 异常的CMGC激酶活性与癌症的发展和进展有关,使它们成为关键的治疗点.
研究的目的:
- 审查CMGC激酶在癌症生物学和信号通路中的作用.
- 总结目前针对CMGC激酶的激酶抑制剂,并讨论挑战.
- 探索针对CMGC激酶的有效癌症治疗的未来策略.
主要方法:
- 在癌症中对CMGC激酶的文献综述.
- 分析当前的激酶抑制剂疗法和耐药性机制.
- 讨论基因组研究中的新兴治疗方法和奥米克.
主要成果:
- CMGC 激酶是癌症信号传递,扩散和生存的组成部分.
- 现有的抑制剂 (例如CDK4/6,BRAF/MEK) 显示出临床成功,但面临耐药性和脱问题.
- 准蛋白质与蛋白质相互作用和合成杀伤性提供了新的治疗途径.
结论:
- 了解CMGC激酶通路和相互作用对于癌症治疗至关重要.
- 开发更有选择性的抑制剂和新的策略对于克服治疗挑战至关重要.
- 未来的研究重点是奥米克和先进的准方法,将提高癌症治疗的疗效.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
09:24Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing
Published on: June 9, 2016
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of Cdk Activity
